Industry news

• Russia Plans to Make 5 mln Doses of COVID-19 Vaccine Per Month in December-January

  14 August 2020 GMP News

  Russia plans to make 5 million doses of the coronavirus vaccine per month in December-January, Director of the Gamaleya National Research Center for Epidemiology and Microbiology Alexander Gintsburg told reporters on Wednesday.

• COVID-19 vaccine delivery will be one of the biggest logistical challenges in modern history

  14 August 2020 GMP News

  The International Air Cargo Association (TIACA) and Pharma.Aero have joined forces to develop global guidance for the air cargo industry to enable optimal transportation of the COVID-19 vaccine. The guidance will be developed gradually in four work packages through a joint working group to ensure feedback from all stakeholders in the supply chain of air cargo and pharmaceuticals said in a press release.

• The creation of an effective coronavirus vaccine is a landmark event for the entire world

  13 August 2020 GMP News

  An orbital station, a strand of the coronavirus, is hooked onto the adenovirus, harmless to humans, like a launch vehicle, and it can also be launched inside the human body. After that, immunity is developed both for the “launch vehicle” and the “orbital station”. As a follow-up to this successful procedure, three weeks later the same “orbital station” is launched onto another “launch vehicle”, i.e. a different adenovirus.

• AI may help treat pulmonary disorders and cancers

  13 August 2020 Marchmont Innovation News

  A Russian company called Intellogic has developed a new artificial intelligence enhanced method of chest X-ray analysis for pneumonia. At the heart of the solution is the company’s Botkin.AI platform.

• Russia is First to Register COVID-19 Vaccine Worldwide

  12 August 2020 GMP News

  Russia’s President Vladimir Putin, opening a meeting with the state officials, reported of the registration in Russia of the first vaccine worldwide against the coronavirus infection.

• Why pharma firms would benefit from a modular approach to working with product labelling

  12 August 2020 David Bennett / European Pharmaceutical Review

  According to David Bennett, securing and building trust in the label, brand and process of a highly regulated industry player in a complex age will demand a new approach.

• The Malaysian response to COVID-19: building preparedness for ‘surge capacity’, testing efficiency and containment

  11 August 2020 Dr Fifa Rahman / European Pharmaceutical Review

  At the time of writing, there have been over 7.6 million cases and over 425,000 deaths from COVID-19 globally. In April and May 2020, these deaths were initially dominated by five countries in the West: the US, Italy, the UK, Spain and France. Since then, Brazil has entered the top five and displaced the UK.

• Russian President Tasks Cabinet With Ensuring Funding for Flu, COVID-19 Vaccination

  11 August 2020 GMP News

  Russian President Vladimir Putin has tasked the government with ensuring funding for flu and coronavirus vaccination after vaccines are registered, noting that up to 60 percent of Russians should be vaccinated against flu.

• COVID-19: unique research of Russian scientists in genomic and protein engineering

  10 August 2020 GMP News

  Scientists of the Institute of Chemical Biology and Fundamental Medicine of the Siberian Branch of the Russian Academy of Sciences (ICBFM SB RAS) will conduct a study to search for substances withstanding the effect of the coronavirus protein, which protects it from many antiviral preparations. It is planned to find such compositions within two years.

• Moscow’s Gamelei Center could register the world’s first coronavirus vaccine on August 12

  10 August 2020 GMP News

  Moscow’s Gamelei Center could register the world’s first coronavirus vaccine on August 12, Russia’s deputy health minister has revealed. Oleg Gridnev says medical workers and the elderly will be given priority for immunization.